For patients with a BMI of 30 to 35 who dont have significant obesity-related health problems, semaglutide or tirzepatide may be sufficient to reach a healthy weight
Most recently, Ro launched Novo's new Wegovy pill on its direct-to-patient platformmaking the pill an option to patients nationwide on day one of its market availability
Maresca, an endocrinologist in the pediatric bariatric program at Hackensack University Medical Center, said adolescent users lose an average of 16.1% of their body mass index
I eat healthy and exercise daily
Quick Answer: GLP-1 receptor agonists do not directly cause frequent urination as a pharmacological effect, though some patients may experience urinary changes due to indirect factors like weight loss, improved glycemic control, or hydration changes
These products offer a holistic approach to health, focusing on improving your gut microbiome to achieve sustainable results